September 25, 2024 10:29 AM EDTUpdated September 27, 09:32 AM
News Briefing

Cor­rect­ed: Sanofi inks deal with I-Mab spin­out; Wave dis­clos­es $175M of­fer­ing on heels of DMD da­ta

ENDPOINTS

Plus, news about BioAge, Ful­crum Ther­a­peu­tics and Ar­cutis Bio­ther­a­peu­tics:

Sanofi snags Greater Chi­na rights to CD73 an­ti­body: The French phar­ma

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times